Quick Answer
ONCOLYTICS BIOTECH INC reported Stockholders Equity of -$3.80 million for the year ending 2025.
- ONCOLYTICS BIOTECH INC showed a decrease of -215.2% in Stockholders Equity from 2024 to 2025.
- This data is from ONCOLYTICS BIOTECH INC's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), ONCOLYTICS BIOTECH INC's Stockholders Equity has declined by 119.4%.
- Historical annual values: Fiscal year 2025: -$3.80 million | Fiscal year 2024: $3.30 million | Fiscal year 2023: $19.60 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: